PPARG and differentiated thyroid carcinoma: Moreover, a new PPAR-γ ligand inhibits TGF-β1-induced EMT, migration, and invasion of papillary thyroid carcinoma cells through the p38 MAPK signaling pathway in a PPARγ-dependent manner [45].